Monsanto’s Annual Pipeline Update Provides a Look into Agriculture’s Future

  Monsanto’s Annual Pipeline Update Provides a Look into Agriculture’s Future

Company Achieves Record Year In Project Advancements Across Diverse Platforms
With Game-Changing Technologies Like Intacta RR2 PRO^™ And FieldScripts^®
Among Products Headed To Market

Business Wire

ST. LOUIS -- January 8, 2014

Monsanto Company’s (NYSE: MON) annual research and development update marks
the company’s largest advancement of products to date. The agricultural
company announced today a record 29 products progressed in its pipeline with
five of those headed to the commercial marketplace. Monsanto’s advancements
include products across all of its platforms, including breeding,
biotechnology, and new technology areas such as Integrated Farming Systems^®
and agricultural biologicals.

“Monsanto’s annual pipeline update provides a window into agriculture’s future
– and, specifically, how breeding, biotechnology, biologicals and improved
agronomics can meet the challenges of feeding a growing planet while using
resources more efficiently,” said Robb Fraley, Ph.D., Monsanto’s chief
technology officer. “From rural communities in America, to the plains of
Sub-Saharan Africa, our scientists and breeders are working to provide farmers
with innovations that can help them get the most out of every acre. I am
particularly proud as this year’s advancements highlight the breadth of our
R&D efforts and the truly integrated approach we are taking in order to
deliver a total system of solutions that can offer additional choice for our
farmer customers.”

Pipeline Highlights

  *Nearly 30 of the company’s more than 70 pipeline projects advanced phases
    this year.
  *A record five products graduated from the pipeline, including Intacta RR2
    PRO^™ soybeans, FieldScripts^® variable rate seeding in corn and Root-Knot
    Nematode Resistance within the cotton breeding pipeline.
  *Some of the most breakthrough progress was delivered from the company’s
    newest technology platforms, including more than 10 advancements across
    its Integrated Farming Systems^® and agricultural biologicals platforms.
  *In addition to the 29 project advancements, Monsanto will have three
    projects in its Ground Breakers^® on-farm testing program this year.
    Projects include Vistive^® Gold soybeans, Roundup Ready 2 Xtend^™ soybeans
    and Bollgard^® II XtendFlex^™ cotton.

“Monsanto is headed in the right direction with science-based approaches and
new technologies for farmers,” said Jeff Frank, a FieldScripts^® Ground
Breakers^® farmer in Auburn, Iowa.“The data driven, scientific technologies
Monsanto is developing are things we’ve never had before. As farmers, we have
to take advantage of any opportunity we can to increase our yield potential.
If we don’t think progressively, we won’t grow enough crops to feed a growing

Biotechnology Platform

Monsanto has a pipeline of biotechnology projects in development, including
next-generation insect control and herbicide tolerance agronomic trait
projects as well as yield and stress work in collaboration with BASF Plant
Science. This year’s nine biotechnology advancements include the launch of
Intacta RR2 PRO^™ soybeans and next-generation products like SmartStax^® PRO
corn (formally Corn Rootworm III), Second-Generation Intacta RR2 PRO soybeans,
Third-Generation Herbicide Tolerant soybeans and Bollgard^® III cotton.

Breeding Platform

In addition to annual germplasm improvements, this year’s breeding pipeline
advanced seven projects within the industry’s most-advanced disease resistance
breeding program. Project highlights include enhanced resistance to
Anthracnose Stalk Rot and Gray Leaf Spot in corn and Soybean Cyst Nematode, as
well as Phytophthora Resistant Peppers, Bacterial Wilt Resistant Tomatoes and
Downy Mildew Resistant Lettuce.

Biologicals Platform

Five products within Monsanto’s agricultural biologicals platform are
advancing as researchers carry on their work to increase crop health and
productivity. Monsanto and the farmer customers it serves share a need to
continuously meet the world’s growing demand in a sustainable way. Investing
in the research and development of agricultural biological technologies is
another step in that direction. Highlighted advancement in this platform
include BioDirect^™ Tospovirus Control, BioDirect^™ Colorado Potato Beetle and
BioDirect^™ Bee Health, as well as the addition of Microbials Yield and
Microbials Plant Health to the pipeline’s discovery phase.

Integrated Farming Systems Platform

Monsanto featured eight advancements in its Integrated Farming Systems^®
platform which is dedicated to helping farmers get more from every acre by
integrating expertise in seed science, field science, data analysis and
precision equipment to develop solutions optimized for the conditions of a
farmer’s field. Advancing products include Variable Rate Soy FieldScripts^®,
Multi-Hybrid Corn FieldScripts^® and Weather-Enhanced FieldScripts^® as well
as the launch of FieldScripts^® in corn.

Monsanto also highlighted the launch of The Climate Corporation’s Climate
Pro^™, a revolutionary web and mobile service that increases a farmer’s
profitability through customized field recommendations that maximize yield and
minimize costs.


For more information on Monsanto’s complete research and development pipeline,
including a list of all 29 projects that advanced phases this year, visit Monsanto today also announced the company’s
financial results for its fiscal 2014 first quarter, which included an update
of projects within the company’s R&D pipeline. For more information about
today’s earnings announcement, see the press release and supporting resources
available at

About Monsanto Company

Monsanto Company is a leading global provider of technology-based solutions
and agricultural products that improve farm productivity and food quality.
Monsanto remains focused on enabling both small-holder and large-scale farmers
to produce more from their land while conserving more of our world’s natural
resources such as water and energy. To learn more about our business and our
commitments, please visit: Follow our business on Twitter^®
at, on the company blog, Beyond the Rows at, or subscribe to our News Release RSS Feed.

Cautionary Statements Regarding Forward-Looking Information

Certain statements contained in this release are "forward-looking statements,"
such as statements concerning the company's anticipated financial results,
current and future product performance, regulatory approvals, business and
financial plans and other non-historical facts. These statements are based on
current expectations and currently available information. However, since these
statements are based on factors that involve risks and uncertainties, the
company's actual performance and results may differ materially from those
described or implied by such forward-looking statements. Factors that could
cause or contribute to such differences include, among others: continued
competition in seeds, traits and agricultural chemicals; the company's
exposure to various contingencies, including those related to intellectual
property protection, regulatory compliance and the speed with which approvals
are received, and public acceptance of biotechnology products; the success of
the company's research and development activities; the outcomes of major
lawsuits and the previously-announced SEC investigation; developments related
to foreign currencies and economies; successful operation of recent
acquisitions; fluctuations in commodity prices; compliance with regulations
affecting our manufacturing; the accuracy of the company's estimates related
to distribution inventory levels; the company's ability to fund its short-term
financing needs and to obtain payment for the products that it sells; the
effect of weather conditions, natural disasters and accidents on the
agriculture business or the company's facilities; and other risks and factors
detailed in the company's most recent Form 10-K Report to the SEC. Undue
reliance should not be placed on these forward-looking statements, which are
current only as of the date of this release. The company disclaims any current
intention or obligation to update any forward-looking statements or any of the
factors that may affect actual results.


Monsanto Company
Charla Lord, 314-694-2993
Press spacebar to pause and continue. Press esc to stop.